VASC On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
text size: T | T
Back to Snapshot
Company Description

Contact Info

6464 Sycamore Court North

Minneapolis, MN 55369

United States

Phone: 763-656-4300

Fax: 877-656-4251

Vascular Solutions, Inc., a medical device company, focuses on providing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The company’s product line consists of approximately 90 devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists, and vein practices worldwide. Products and Services GuideLiner Catheters The GuideLiner catheter is designed to increase backup support and allow deep-seating of the guide catheter for coaxial alignment, distal device delivery, and selective delivery of contrast. The device is especially useful in complex interventions. The company has CE Mark and launched GuideLiner in Europe; and has 510(k) clearance and launched the device in the U.S. The company also offers the second generation of its GuideLiner catheter; and the third generation version, GuideLiner V3, which features a polymer ‘half-pipe’ collar to enhance stent and wire deployment. In addition, the company has Shonin approval from the Japanese Ministry of Health, Labour and Welfare for sale of the GuideLiner in Japan. Pronto Catheters The company’s Pronto extraction catheters are designed to remove fresh, soft thrombus, and emboli from the arteries of patients suffering a heart attack. The Pronto catheters feature a proprietary distal tip and large extraction lumen that can be delivered into arteries to remove blood clots using simple vacuum suction. The company has CE Mark approval and Food and Drug Administration (FDA) clearance for sale of Pronto catheters in the United States. It also offers the third generation design of Pronto, named the Pronto V3; and the Pronto V4, which utilizes an embedded longitudinal wire for maximum extraction with enhanced deliverability and kink resistance. In addition to the Pronto V3 and V4, the company developed and launched four additional versions of extractions catheters: the Pronto-Short, Pronto 035, Pronto LP, and Pronto XL. The Pronto-Short is a shorter catheter with a larger diameter, designed for use in clotted dialysis grafts. The Pronto 035 is a larger version, designed for use in large vessels. The Pronto LP is a low-profile version, designed for use in smaller vessels. The Pronto XL extraction catheter is a larger version with either a straight or pigtail tip, designed for use in very large vessels. Vein Catheter Reprocessing The company has a license agreement with Northeast Scientific, Inc. (NES), under which it sells a reprocessing service to customers utilizing the ClosureFAST radiofrequency catheter in the treatment of varicose veins in the United States. It also markets this service to vein clinics in the U.S. The ClosureFAST catheter is owned and marketed by a subsidiary of Medtronic plc. Under the reprocessing service provided by NES, the customer sends used ClosureFAST catheters to NES, where they are inspected, cleaned, tested, repackaged, resterilized, and shipped back to the customer. In addition to this basic reprocessing service, the company also purchases used ClosureFAST catheters from vein clinics and have them reprocessed by NES for sale to customers in the U.S. In 2015, the company signed a revised agreement with NES that grants it exclusive rights to market the ClosureFAST reprocessing service in the U.S. through December 31, 2021. Micro-Introducer Kits Micro-introducers are access kit products used to gain percutaneous access to the vasculature for performing arterial and venous catheterization procedures. The company offers various introducer products, including a line of kits and various specialty guidewires. Hemostatic Patches The company’s hemostat products primarily utilize thrombin, a bovine-derived blood clotting protein, to deliver a rapid seal of bleeding with various shelf-stable configurations. The company’s primary hemostat product includes the D-Stat Dry hemostat bandage, which has regulatory clearance and is sold in the United States and international markets. The D-Stat Dry is a version of its proprietary blood clotting substance that is lyophilized (freeze-dried) into a gauze pad and combined with an adh

 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

VASC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VASC.
View Industry Companies
 

Industry Analysis

VASC

Industry Average

Valuation VASC Industry Range
Price/Earnings 87.2x
Price/Sales 5.2x
Price/Book 6.2x
Price/Cash Flow 73.1x
TEV/Sales 5.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact VASCULAR SOLUTIONS INC, please visit www.vascularsolutions.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.